BioMAP Diversity Early Screening Services
- Year:
- 2022
The robust BioMAP® phenotypic profiling you trust, in the high quantity screening format you need.
BioMAP Early Screening (ES) services offer an expedited path to physiologically relevant, disease-focused data for large numbers of compounds. Quickly triage, prioritize, and classify your compounds for preclinical success based on translational biomarker activities in human disease models.